1.
Percutaneous coronary intervention through transulnar approach:12 cases report
经尺动脉径路行经皮冠状动脉介入治疗12例
2.
Emergency percutaneous coronary interventional in treatment of 35 cases of acute myocardial infarction
急诊经皮冠状动脉介入治疗急性心肌梗死35例
3.
Outcome of Percutaneous Coronary Intervention in Coronary Artery Disease with Severe Left Ventricular Dysfunction;
冠心病左心功能不全患者经皮冠状动脉介入治疗疗效研究
4.
Effect of percutaneous coronary interventions on heart function in patients with coronary heart disease and heart failure disease
经皮冠状动脉介入治疗对冠心病合并心力衰竭患者疗效评价
5.
Optical coherence tomography in assessment of coronary aneurysms after placement of drug-eluting stents
光学相干断层成像评价经皮冠状动脉介入治疗术后动脉瘤
6.
Facilitated Percutaneous Coronary Intervention(PCI)via Trans-radial Artery Approach in the Treatment of Acute Myocardial Infarction
桡动脉途径易化经皮冠状动脉介入治疗急性心肌梗死效果观察
7.
The Forecast Effect of QT Dispersion on Prognosis of Percutaneous Coronary Intervention;
QT离散度对冠心病患者经皮冠状动脉介入治疗预后的影响
8.
Percutaneous Coronary Intervention in Patients of Coronary Disease--A Study about Quality of Life;
经皮冠状动脉介入治疗对冠心病病人生活质量的影响
9.
C-reactive protein change with coronary heart disease after percutaneous coronary intervention
冠心病经皮冠状动脉介入治疗术前后C反应蛋白变化的临床分析
10.
The clinical outcomes of Partner drug-eluting stent in emergent PCI
Partner药物洗脱支架在急诊经皮冠状动脉介入治疗中的临床疗效
11.
Investigation of Coagulation System After Percutaneous Coronary Intervention
经皮冠状动脉介入治疗术后凝血系统动态变化的研究
12.
Changes and Clinical Significance of Serum Ischemia Modified Albumin on Percutaneous Coronary Intervention;
缺血修饰蛋白在经皮冠状动脉介入治疗术中的变化及其临床意义
13.
Significance and Changes of Myocardial Injury Markers in Patients with Percutaneous Coronary Intervention;
经皮冠状动脉介入治疗术中心肌损伤标志物的变化及意义
14.
Significance and Effects of Serum Ischemia Modified Albumin on Percutaneous Coronary Intervention;
经皮冠状动脉介入治疗对血清缺血修饰白蛋白的影响及其意义
15.
Integration Analysis of No-reflow Phenomenon after Percutaneous Coronary Intervention(PCI);
经皮冠状动脉介入治疗(PCI)后无复流现象的综合解析
16.
The Effect of Trimetazidine on Serum Level of cTnI、hs-CRP and MDA in Patients with CHD before and after PCI
曲美他嗪对经皮冠状动脉介入治疗前后血清cTnI、hs-CRP和MDA的影响
17.
The application of low molecular weight heparin-enoxaparin in percutaneous coronary intervention
低分子肝素——依诺肝素在经皮冠状动脉介入治疗围手术期的应用
18.
Percutaneous coronary intervention in treatment of heart failure derived from geriatric ischemic cardiomyopathy
经皮冠状动脉介入治疗对老年缺血性心肌病心功能和预后的影响